問卷

TPIDB > Study Site

Study Site



Kaohsiung Municipal Ta-Tung Hospital

  • 0

    Total Beds

  • 0

    Total Doctors

  • pidb_editor
  • 801Kaohsiung CityKaohsiung Qianjin

篩選

List

16Cases

2021-11-01 - 2026-06-30

Phase III

Active
A Phase 3, Open-Label, Randomized Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in Patients with EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Osimertinib Failure.
  • Condition/Disease

    NSCLC

  • Test Drug

    JNJ-61186372 (Amivantamab)JNJ-73841937 (Lazertinib)

Participate Sites
8Sites

Not yet recruiting5Sites

Recruiting2Sites

Terminated1Sites

2018-06-26 - 2030-12-31

Phase II

Active
A Phase 2 Open-Label Study of the Efficacy of Venetoclax in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia in the Presence of 17p Deletion
  • Condition/Disease

    Chronic Lymphocytic Leukemia

  • Test Drug

    Venetoclax

Participate Sites
8Sites

Recruiting7Sites

2023-11-01 - 2027-12-31

Phase II/III

Active
A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)
  • Condition/Disease

    IgA Nephropathy 、Berger Disease

  • Test Drug

    Atacicept

Participate Sites
6Sites

Not yet recruiting5Sites

Recruiting1Sites

2023-12-21 - 2028-01-21

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2024-01-25 - 2029-01-31

Phase III

Active
A 52-Week, Open-Label Extension Study of ACP-204 in Adults with Alzheimer’s Disease Psychosis
  • Condition/Disease

    Alzheimer’s Disease Psychosis

  • Test Drug

    tablets

Participate Sites
7Sites

Recruiting7Sites

2024-11-05 - 2027-02-02

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Not yet recruiting2Sites

Recruiting5Sites

2013-11-15 - 2019-12-31

Phase II

A Randomized, Double-Blind, Vehicle-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of CSTC1 in Patient with Diabetic Foot Ulcers
  • Condition/Disease

    Diabetic Foot Ulcers

  • Test Drug

    CSTC1

Participate Sites
3Sites

Terminated3Sites

1 2